GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review.

Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N.

Open source

DOI
10.1016/j.diabres.2025.112924
Published
2025-09-27
Container
Diabetes Res Clin Pract
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.diabres.2025.112924,
  title = {GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review.},
  author = {Pantazopoulos D and  Gouveri E and  Papazoglou D and  Papanas N.},
  year = {2025},
  journal = {Diabetes Res Clin Pract},
  doi = {10.1016/j.diabres.2025.112924},
  url = {https://doi.org/10.1016/j.diabres.2025.112924}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review.
AU  - Pantazopoulos D
AU  -  Gouveri E
AU  -  Papazoglou D
AU  -  Papanas N.
PY  - 2025
JO  - Diabetes Res Clin Pract
DO  - 10.1016/j.diabres.2025.112924
UR  - https://doi.org/10.1016/j.diabres.2025.112924
ER  - 

APA

D, P., E, G., D, P., & N., P. (2025). GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review.. Diabetes Res Clin Pract. https://doi.org/10.1016/j.diabres.2025.112924

Source records